Days

Hours

Minutes

Seconds

Welcome Message

Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE

Dear Friends and Colleagues,

It gives me great pleasure to invite you to the 7^th UAE International Conference on Antimicrobial Resistance (ICAMR), which will be held on 23-24 February 2024 in Raffles Hotel Dubai, United Arab Emirates.

ICAMR 2023 promises you an enriching scientific and educational gathering, which will shed light on the latest advances in research and practice through presentations and interactive discussions with current, in-depth quality scientific content in the field of Antimicrobial Resistance. The conference is organized by the National Antimicrobial Resistance Committee in UAE.

We believe that the conference will provide an exceptional opportunity for everyone to share and acquire knowledge and experience on a wide spectrum of topics that are related to microbiology, infectious disease, infection control, and antimicrobial stewardship in addition to an opportunity to meet and rub shoulders with the experts in the field and innovative educators.

We look forward to welcoming you to ICAMR 2024.

Sincerely,

Global Health Leader

Supported by

In Collaboration with

2023 Endorsed By

Scientific & Organizing Committee

Organizing Committee

Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, United Arab Emirates

Dr. Ashraf El Houfi
Chairman of the Infection Control-
Committee Dubai Hospital
Consultant ICU
Dubai Hospital
Dubai, United Arab Emirates

Ms. Abeer Rajeh
RN-BSN
Infection control Expert
Quality and accreditation Department
Emirates Health Services
Dubai, United Arab Emirates

Ms. Husna Nazar
Medical Secretary
Al Kuwait Hospital Dubai
Dubai, United Arab Emirates

Mr. Joseph Tannous
Infection control Specialist
Central Infection Control
Emirates Health Services

Dr. Sohanlal Thiruvoth
Consultant Internal Medicine
Chair of Medicine and ASP
Member of UAE National ASP committee
Member of ESCMID, ESGAP, BSAC
Prime Hospital
Dubai, UAE

Dr. Jens Thomsen MD MPH
Consultant, Clinical Microbiology and ID Epidemiology
Section Head, Environmental Health, Abu Dhabi Public Health Center (ADPHC)
Chair, UAE National Sub-Committee for AMR Surveillance (MOHAP)
President, Emirates Society for Clinical Microbiology (ESCM)
Adjunct Associate Clinical Professor, Khalifa University, Abu Dhabi
Abu Dhabi, United Arab Emirates

Scientific Committee

Dr. Zulfa Al Deesi
Acting Head of Pathology Section
Head of Microbiology and infection Control Unit
Latifa Women and Children Hospital
Pathology & Genetics Department
Dubai, United Arab Emirates

Dr. Ahmed Al Hammadi
Consultant
President, Emirates Infectious Disease Society
Infectious Disease
Tawam Hospital
Al Ain, United Arab Emirates

Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, United Arab Emirates

Dr. Nehad Alshirawi
Intensive Care Consultant and
Head of ICU Department
Intensive Care
Al Fujairah Hospital
Fujairah, United Arab Emirates

Ms. Duaa Salem Jawhar
Master in Clinical Pharmacy
American Board Infectious Disease
Infectious Disease Clinical Pharmacist
Co-leader Antimicrobial Stewardship programe
Pharmacy Department
Saqr Hospital
Ras Al Khaimah, United Arab Emirates

Ms. Abeer Rajeh
RN-BSN
Infection control Expert
Quality and accreditation Department
Emirates Health Services
Dubai, United Arab Emirates

Mr. Elias Tannous
BSN-MBA-CIC
Manager, Infection Control
Co-chair Infection Control Committee
Quality and Patient Safety Institute
Cleveland Clinic
Abu Dhabi, United Arab Emirates

Mr. Joseph Tannous
Infection Control Consultant
Central Infection Control
Emirates Health Services
Dubai, United Arab Emirates

Dr. Sohanlal Thiruvoth
Consultant Internal Medicine
Chair of Medicine and ASP
Member of UAE National ASP committee
Member of ESCMID, ESGAP, BSAC
Prime Hospital
Dubai, United Arab Emirates

Dr. Jens Thomsen
Section Head, Environmental Health
Environmental and Occupational Health and Safety
Abu Dhabi Public Health Center
Abu Dhabi, United Arab Emirates

Faculty

Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE

Dr. Ahmed Al Hammadi
Consultant
President, Emirates Infectious Disease Society
Infectious Disease
Tawam Hospital
Al Ain, UAE

Dr. Majid Al Shamrani
Executive Director
Infection Prevention and Control Program
King Abdulaziz Medical City, Ministry of National Guard Health Affairs
Riyadh, Saudi Arabia

Ms. Fatima Saeed Al Memari
Infection Control Officer
Prevention and Control of Infection Department
Ibrahim Bin Hamad Obaidallah Hospital & Obaidallah Geriatric Hospital
Ras AL Khaimah, UAE

Dr. Majid Al Shamrani
Executive Director
Infection Prevention and Control Program
King Abdulaziz Medical City, Ministry of National Guard Health Affairs
Riyadh, Saudi Arabia

Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, United Arab Emirates

Ms. Hajar Ali Aldhanhani
RN, BSN, CIC
Infection Prevention & Control Manager
Tawam Hospital
Al Ain, UAE

Dr. Huda Al Dhanhani
Medical Consultant
Abu Dhabi Health Services Company – SEHA
Abu Dhabi, United Arab Emirates

Dr. Jameela Alsalman
CIC, CMQ
Infectious Disease Consultant
Manama, Bahrain

Ms. Tabrikah Al Shibah
BsN,Msc, TQM, CIC ,CPHQ
Infection Control Officer
Organization development
Quality & Accreditation
NRC
Abu Dhabi, United Arab Emirates

Dr. Nehad Alshirawi
Intensive Care Consultant and Head of ICU Department
Intensive Care
Al Fujairah Hospital
Fujairah, United Arab Emirates

Mrs. Dina Ataig
Infection Control Officer
Prevention and Control of Infection
Saqr Hospital
Ras Al Khaimah, United Arab Emirates

Dr. April Baller
Infection Prevention and Control
Country Readiness Strengthening
WHO Health Emergencies Programme (WHE)
Geneva, Switzerland

Prof. Adrian Brink

Professor and Chair and Head of the Division of Medical Microbiology
Faculty of Health Sciences, National Health Laboratory Services
Institute of Infectious Disease & Molecular Medicine
University of Cape town
Cape town , South Africa

Dr. Miguela Caniza
MD, MPH
Infectious Diseases
St. Jude Children’s Research Hospital
Memphis, Tennessee, USA

Dr. Heba Dada
Director of Antimicrobial Resistance Department
Saudi Public Health Authority
Riyadh, Saudi Arabia

Dr. Ashraf El Houfi
Consultant HOD /Chair infection Control
Intensive Care Unit
Dubai Hospital
Dubai, United Arab Emirates

Dr. Souha Kanj
MD, FACP, FIDSA, FRCP, FECMM, FESCMI
Professor of Medicine,
Associate Dean, for Global Affairs
Head, Division of Infectious Diseases
Department of Internal Medicine
Chair, Infection Control and Prevention Program
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center
Consultant Professor, Duke University Medical Center, Durham, NC
Honorary Dr, Radboud University Medical Center, NL

Prof. Martin Kiernan
Visiting Professor
Richard Wells Research Centre
University of West London
London, UK

Ms. Abeer Rajeh
RN-BSN
Infection Control Expert
Quality and Accreditation Department
Emirates Health Services
Dubai, United Arab Emirates

Dr. Ziad Memish
Senior Infectious Disease Consultant
College of Medicine, AlFaisal University
Director, Research & Innovation Centre
King Saud Medical City, Ministry of Health
Riyadh, Saudi Arabia

Dr. Godfred A Menezes
Professor & Chairperson- Medical Microbiology & Immunology (MMI)
RAK College of Medical Sciences (RAKCOMS)
RAK Medical & Health Sciences University (RAKMHSU)
Clinical Microbiologist – RAK Hospital
Ras Al Khaimah, UAE

Dr. Ali Omrani
Senior Consultant in Infectious Diseases
Infectious Diseases
Hamad Medical Center
Doha, Qatar

Dr. Jehad Abdalla
ID Consultant, SKMC Hospital, Abu Dhabi, UAE
Chair of ASP Committee in SEHA , Abu Dhabi, UAE
Dr. Abdalla is American board certified in Infectious Diseases.
His current area of research and teaching interest includes viral infections, tuberculosis, antimicrobial stewardship, multidrug resistant organisms and prevention of healthcare associated infections
Abu Dhabi, UAE

Prof. Abiola Catherine Senok
Professor of Microbiology & Infectious Diseases
College of Medicine
Mohammed Bin Rashid University Of Medicine and Health Sciences
Dubai, United Arab Emirates

Dr. Jacqueline Sneddon
FRPharmS
Programmes Manager
British Society for Antimicrobial Chemotherapy
Member of RPS Scottish Pharmacy Board
PhD in Medicinal Chemistry
MSc in Clinical Pharmacy
Scotland, United Kingdom

Mr. Elias Tannous
BSN-MBA-CIC
Manager, Infection Control
Co-chair Infection Control Committee
Quality and Patient Safety Institute
Cleveland Clinic
Abu Dhabi, United Arab Emirates

Mr. Joseph Tannous
Infection Control Consultant
Central Infection Control
Emirates Health Services
Dubai, UAE

Mr. Ajish Thankachan
RN, Pg DIC, CIC
Senior Infection Control Practitioner
Emirates Health Services
Dubai, United Arab Emirates

Dr. Sohanlal Thiruvoth
Consultant Internal Medicine
Chair of Medicine and ASP
Member of UAE National ASP Committee
Member of ESCMID, ESGAP, BSAC
Prime Hospital
Dubai, UAE

Dr. Jens Thomsen
Section Head, Environmental Health
Environmental and Occupational Health and Safety
Abu Dhabi Public Health Center
Abu Dhabi, UAE

Prof. Dr. Heiman Wertheim
Medical Micorbiology
Radboudumc
Nijmegen, Netherlands

Prof. Mohammad Yaqub
Assistant Professor at Mohamed bin Zayed University of Artificial Intelligence
Abu Dhabi, United Arab Emirates

Scientific Program

Learn about the schedule, topics and workshops of ICAMR conference.

Conference Main Topics

Antimicrobial Stewardship Programs
AMR: updates, novel technology and artificial intelligence
Global infection control strategy to combat AMR
Challenges and research priorities to combat AMR
Mass gathering and AMR
Country readiness and strengthening for pandemics
GCC achievements on combatting AMR
Challenges and solutions of AMR during COVID-19
AMR in paediatric services
Prevention of healthcare-associated infections
Surveillance of multidrug resistance organisms
Implementation science and business case for infection control
Environmental disinfection in healthcare settings
Developmental path of the infection preventionist (CBIC)
Assessing risks in building projects

Target Specialities

Infection disease physicians
Internal medicine physicians
Microbiologist
Pharmacist
Infection control practitioners
Critical care physicians
Lab technicians
Quality officers
Public health officers
Internal Medicine Specialists
Family and Primary Care Physicians
Medical Informatics
Nursing
Nurses, Nurse Practitioners
Researchers
Biomedical Engineers
Hospital and Corporate Administrators and Executives

Learning Objectives

Antimicrobial Stewardship Programs: interventions and outcomes
UAE AMR surveillance updates
GCC: experience and strategies to combat AMR
Strengthening country readiness for pandemics
AMR in mass gathering and implications for public health
Strategies, technology and artificial intelligence to combat AMR
Challenges and research priorities to combat AMR
Implementation of science in the fight against HAI
Innovative approach to prevent MDRO
Prevention and management of healthcare-associated infections
Business case for Infection, Prevention and Control Programs
Environmental hygiene for patient safety
Improving healing environment in building projects
Certification: preparation and tips for infection preventionists

Download Scientific Program

Abstract Submission

To submit an abstract, please read all of the instructions below.

Abstract Submission

To submit an abstract, please read all of the instructions below.

You are invited to submit an abstract for the 7^th UAE’s International Hybrid Conference on Antimicrobial Resistance (ICAMR) on 23 & 24 February 2024.

Abstract submission deadline: Wednesday, 10 January 2024 – 11:59 PM
Notification on Acceptance/Rejection: Between 20 to 25 January 2024 – 11:59 PM
Please note that only electronic submissions are accepted.

Language & Content
All abstracts must be submitted in English using the online submission form on the www.ICAMR-UAE.com website with a limit of 2,245 characters (approx. 300 words).

General Conditions

1. Abstracts must be submitted maximum by Wednesday, 10 January 2024 – 11:59 PM.
2. Abstracts are Accepted as Poster presentations only.
3. All accepted abstracts will be presented as posters on 25 January 2024 at 11:59 PM.
4. Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 14 days after notification on acceptance.
5. If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.

Presenting Author and Registration

Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
All presenters should be registered to the conference before 6 January 2024.
Abstract submitters must consent to the Policies of Abstract Submission.
National Committee of AMR reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration at the latest 14 days after notification on acceptance.

Contents of your Abstract

Original works and Case Reports about Microbiology, Infectious Disease, Infection Control, and Antimicrobial Resistance will be accepted.
The abstract text body is limited to 2,245 characters (Approx. 300 words) including spaces. (Please do not include the title and the author’s information in the text body (names and affiliations), this information will be required in the web form)
The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.
The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present, your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
All abbreviations must be defined in first use.
No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of the author(s) and their institution(s), when you submit your abstract online
Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Conference scientific committee reserves the right to replace any brand name with a generic name without further notice.
Images that are uploaded to follow the abstract are not guaranteed inclusion in the conference materials.